Browse > Home / News / Eli Lilly, Chi-Med Team Up on Cancer Drugs

• Recent Posts

  • Qingdao Longxinweiye Truck Commercial Co., Ltd.
  • Qingdao Aucma Electric Science & Technology Co., Ltd.
  • Qingdao Wontide Co., Ltd.
  • Monopoly on Coke
  • China’s Courts, Tenth “Best” Out of Twelve. :: China Law Blog
  • What of China’s relaxed environment for foreign reporters? :: Imagethief
  • Cool underwear commercial :: MOBIZ
  • Qingdao Free Trade Zone Bri-color Int’l Trading Corp., Ltd.
  • Qingdao Jinhaiyuan Industrial Group Co., Ltd.
  • Qingdao Sinorient International Co., Ltd.

Eli Lilly, Chi-Med Team Up on Cancer Drugs

Eli Lilly & Co. announced it will work with a unit of Hutchison China MediTech Ltd., known as Chi-Med, to develop drugs to treat cancer and inflammatory diseases. Lilly will hand over preclinical research and development on several compounds to the pharmaceuticals company. Chi-Med, which is listed on London’s Alternative Investment Market, is a subsidiary of Hutchison Whampoa Ltd.
Read Original Post Here

Rate this company:

• Categories

  • Agriculture
  • Announcements
  • Apparel & Fashion
  • Articles
  • Automobile
  • Building, Construction & Real Estate
  • Chemicals
  • Computer Hardware & Software
  • Electrical Equipment & Supplies
  • Electronic Components & Supplies
  • Energy & Enviroment
  • Food & Beverage
  • Furniture & Furnishings
  • Gifts & Crafts
  • Home & Industrial Supplies
  • Home Appliances
  • Lights & Lighting
  • Luggage, Bags & Cases
  • Metals, Minerals & Materials
  • News
  • Office Supplies
  • Packaging & Paper
  • Recommended
  • Security & Protection
  • Sports & Entertainment
  • Telecommunications
  • Textiles & Leather Products
  • Timepieces, Jewelry, Eyewear
  • Toys & Games
  • Trade Misc
  • Transportation

• Resources

• 
  
  
  
  
  

Top China Suppliers • powered by WordPress • Using RockinBizRed theme by Nathan Rice.